| 1. |
Zhang Y, Buchholz F, Muyrers J.P.P., and Stewart A.F. (1998) A new logic for DNA engineering using recombination in Escherichia
coli. Nat. Genet. 20, 123–128.
|
| |
| 2. |
Muyrers, J.P.P., Zhang, Y., Testa, G., and Stewart, A.F. (1999) Rapid modification of bacterial artificial chromosomes by
ET-recombination. Nucleic Acids Res. 27, 1555–1557.
|
| |
| 3. |
Lee, E.C., Yu, D., Martinez de Velasco, J., Tessarollo, L., Swing, D.A., Court, D.L., Jenkins, N.A., and Copeland, N.G. (2001)
A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning
of BAC DNA. Genomics
73, 56–65.
|
| |
| 4. |
Shizuya, H., Birren, B., Kim, U.J., Mancino, V., Slepak, T., Tachiiri, Y., and Simon, M. (1992). Cloning and stable maintenance
of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc. Natl. Acad. Sci. USA
89, 8794–8797.
|
| |
| 5. |
Giel-Moloney, M., Krause, D.S., Chen, G., Van Etten, R.A., and Leiter, A.B. (2007) Ubiquitous and uniform in vivo fluorescence
in ROSA26-EGFP BAC transgenic mice. Genesis
45, 83–89.
|
| |
| 6. |
Hochedlinger, K., Yamada, Y., Beard, C., and Jaenisch, R. (2005) Ectopic expression of Oct-4 blocks progenitor-cell differentiation
and causes dysplasia in epithelial tissues. Cell
121, 465–477.
|
| |
| 7. |
Wallace, H.A., Marques-Kranc, F., Richardson, M., Luna-Crespo, F., Sharpe, J.A., Hughes, J., Wood, W.G., Higgs, D.R., Smith,
A.J. (2007) Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence. Cell. 128, 197–209.
|
| |
| 8. |
Gong, S., Zheng, C., Doughty, M.L., Losos, K., Didkovsky, N., Schambra, U.B., Nowak, N.J., Joyner, A., Leblanc, G., Hatten,
M.E., and Heintz, N. (2003) A gene expression atlas of the central nervous system based on bacterial artificial chromosomes.
Nature
425, 917–925.
|
| |
| 9. |
Wilson, C.B. and Schoenborn, J. (2006) BACing up the interferon-gamma locus. Immunity
25, 691–693.
|
| |
| 10. |
Ango, F., di Cristo, G., Higashiyama, H., Bennett, V., Wu, P., and Huang, Z.J. (2004) Ankyrin-based subcellular gradient of
neurofascin, an immunoglobulin family protein, directs GABAergic innervation at purkinje axon initial segment. Cell
119, 257–272.
|
| |
| 11. |
Sauer, B. (1993) Manipulation of transgenes by site-specific recombination: use of Cre recombinase. Methods Enzymol. 225, 890–900.
|
| |
| 12. |
Brook, F.A. and Gardner, R.L. (1997). The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. U.S.A. 94, 5709–5712.
|
| |
| 13. |
Evans, M.J. and Kaufman, M.H. (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature
292, 154–156.
|
| |
| 14. |
Coppo, P., Flamant, S., De Mas, V., Jarrier, P., Guillier, M., Bonnet, M.L., Lacout, C., Guilhot, F., Vainchenker, W., and
Turhan, A.G. (2006) BCR-ABL activates STAT3 via JAK and MEK pathways in human cells. Br. J. Haematol. 134, 171–179.
|
| |
| 15. |
Yu, H. and Jove, R. (2004) The STATs of cancer–new molecular targets come of age. Nat. Rev. Cancer
4, 97–105.
|
| |
| 16. |
Kortylewski, M., Jove, R., and Yu, H. (2005) Targeting STAT3 affects melanoma on multiple fronts. Cancer Metastasis Rev. 24, 315–327.
|
| |
| 17. |
Ying, Q.L., Nichols, J., Chambers, I., and Smith, A. (2003) BMP induction of Id proteins suppresses differentiation and sustains
embryonic stem cell self-renewal in collaboration with STAT3. Cell
115, 281–292.
|
| |
| 18. |
Maritano, D., Sugrue, M.L., Tininini, S., Dewilde, S., Strobl, B., Fu, X., Murray-Tait, V., Chiarle, R., and Poli, V. (2004)
The STAT3 isoforms alpha and beta have unique and specific functions. Nat. Immunol. 4, 401–409.
|
| |
| 19. |
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., and Akira, S. (1997) Targeted disruption
of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 94, 3801–3804.
|
| |
| 20. |
Panopoulos, A.D., Zhang, L., Snow, J.W., Jones, D.M., Smith, A.M., El Kasmi, K.C., Liu, F., Goldsmith, M.A., Link, D.C., Murray,
P.J., and Watowich, S.S. (2006) STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood
108, 3682–90.
|
| |
| 21. |
Lee, C.K., Raz, R., Gimeno, R., Gertner, R., Wistinghausen, B., Takeshita, K., DePinho, R.A., and Levy, D.E. (2002) STAT3
is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity
17, 63–72.
|
| |
| 22. |
Jenkins, B.J., Roberts, A.W., Najdovska, M., Grail, D., and Ernst, M. (2005) The threshold of gp130-dependent STAT3 signaling
is critical for normal regulation of hematopoiesis. Blood
105, 3512–20.
|
| |
| 23. |
Chung, Y. J., Park, B. B., Kang, Y. J., Kim, T. M., Eaves, C. J., and Oh, I. H. (2006) Unique effects of Stat 3 on the early
phase of hematopoietic stem cell regeneration. Blood
108, 1208–1215.
|
| |
| 24. |
Moriggl, R., Sexl, V., Kenner, L., Duntsch, C., Stangl, K., Gingras, S., Hoffmeyer, A., Bauer, A., Piekorz, R., Wang, D.,
Bunting, K.D., Wagner, E.F., Sonneck, K., Valent, P., Ihle, J.N., and Beug, H. (2005) Stat5 tetramer formation is associated
with leukemogenesis. Cancer Cell
7, 87–99.
|
| |
| 25. |
Kovacic, B., Stoiber, D., Moriggl, R., Weisz, E., Ott, R.G., Kreibich, R., Levy, D.E., Beug, H., Freissmuth, M., and Sexl,
V. (2006) STAT1 acts as a tumor promoter for leukemia development. Cancer Cell
10, 77–87.
|
| |
| 26. |
Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C., and Darnell, J.E., Jr. (1999) Stat3
as an oncogene. Cell
98, 295–303.
|
| |
| 27. |
Decker, T. and Kovarik, P. (2000) Serine phosphorylation of STATs. Oncogene
19, 2628–37.
|
| |
| 28. |
Giraldo, P. and Montoliu, L. (2001) Size matters: use of YACs, BACs and PACs in transgenic animals. Transgenic Res. 10, 83–103.
|
| |
| 29. |
Yang, X.W., Model, P. and Heintz, N. (1997) Homologous recombination based modification in Escherichia coli and germline transmission
in transgenic mice of a bacterial artificial chromosome. Nat. Biotechnol. 15, 859–65.
|
| |